Trials / Terminated
TerminatedNCT03173885
Investigating the Cryopreserved Blastocyst's ImplantatiOn Potential After Genetic Screening
An RCT Evaluating the Implantation Potential of Vitrified Embryos Screened by Next Generation Sequencing Following Trophectoderm Biopsy, Versus Vitrified Unscreened Embryos in Good Prognosis Patients Undergoing IVF
- Status
- Terminated
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 56 (actual)
- Sponsor
- University Hospital, Ghent · Academic / Other
- Sex
- Female
- Age
- 18 Years – 37 Years
- Healthy volunteers
- Not accepted
Summary
This is a two-arm parallel group randomized controlled trial at the Department of Reproductive Medicine at Ghent University Hospital. Women \>=18 and \<37 years of age undergoing their first or second IVF/ICSI treatment, with at least 2 good quality blastocysts remaining after fresh embryo transfer will be randomized to either transfer of a cryopreserved blastocyst selected based on morphology (standard treatment arm) or transfer of a cryopreserved blastocyst selected based on PGS and morphology (intervention treatment arm).
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DIAGNOSTIC_TEST | Preimplantation Genetic Screening | * laser assisted hatching * trophectoderm biopsy * next generation sequencing |
Timeline
- Start date
- 2017-05-18
- Primary completion
- 2020-02-05
- Completion
- 2020-02-05
- First posted
- 2017-06-02
- Last updated
- 2024-09-19
Locations
1 site across 1 country: Belgium
Source: ClinicalTrials.gov record NCT03173885. Inclusion in this directory is not an endorsement.